Global Pain Management Therapeutics Market

Pain Management Therapeutics Market Size, Share, Growth Analysis, By Drug class(Opioids, NSAIDs), By Indication(Arthritic pain, chronic back pain), By Distribution channel(Online pharmacy, hospital pharmacy) - Industry Forecast 2024-2031

Report ID: SQMIG35F2004 | Region: Global | Published Date: February, 2024
Pages: 276 | Tables: 94 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Pain Management Therapeutics Market size was valued at USD 75976 million in 2019 and is poised to grow from USD 78711.14 million in 2023 to USD 104451.39 million by 2031, growing at a CAGR of 3.6% in the forecast period (2024-2031).

pain management therapeutics market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Teva Pharmaceutical', 'AstraZeneca', 'Pfizer Inc.', 'Johnson & Johnson', 'Novartis AG', 'Abbott Laboratories', 'Eli Lilly and Company', 'GlaxoSmithKline plc', 'Merck & Co., Inc.', 'Endo Pharmaceuticals Inc.', 'Purdue Pharma L.P.', 'Bristol-Myers Squibb Company', 'Boehringer Ingelheim International GmbH', 'Sanofi S.A.', 'Mallinckrodt Pharmaceuticals', 'Mylan N.V.', 'AbbVie Inc.', 'Daiichi Sankyo Company, Limited', 'Mallinckrodt Pharmaceuticals', 'Zoetis Inc.'

The growing cases of various diseases, in addition to the associated pain and aches, are contributing to the expansion of the pain management therapeutics market. Pain can be caused by a variety of conditions, including ulcers, osteoarthritis, chronic arthritis, multiple sclerosis, cancer, and diabetic neuropathy. Pain management therapeutics are effective in treating everything from short-term acute pain to long-term chronic pain. market growth is being stimulated by growing preference for pain management.

The emphasis is increasingly shifting toward personalised drugs, biologics, and quick-acting lifestyle medicines, which account for more than 70% of all medications in development.

North America held the largest pain management therapeutics market share in terms of revenue in 2021, followed by Europe and Asia Pacific, and is predicted to continue the lead during the forecast period. North American companies are heavily involved in research and development efforts for developing new pain management drugs, resulting in driving the pain management therapeutics market.

Related Reports

Ovarian Cancer Diagnostic Market
Buy Now GET FREE SAMPLE
Healthcare Revenue Cycle Management Market
Buy Now GET FREE SAMPLE
AAV Contract Development And Manufacturing Organizations Market
Buy Now GET FREE SAMPLE
Meditation Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Pain Management Therapeutics Market

Product ID: SQMIG35F2004

$5,300
BUY NOW GET FREE SAMPLE